(Q34221194)

31 July 2017

1 reference

title

Epstein-Barr virus and oncogenesis: from latent genes to tumours (English)

1 reference

31 July 2017

0 references

0 references

Lawrence S Young

1 reference

31 July 2017

Paul G Murray

series ordinal

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 August 2003

1 reference

31 July 2017

1 reference

31 July 2017

1 reference

31 July 2017

1 reference

31 July 2017

page(s)

5108-5121

1 reference

Cell growth effects of Epstein-Barr virus leader protein.

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206556

Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206556

Detection of Epstein-Barr virus in invasive breast cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206556

Epstein-Barr virus is present in neoplastic cytotoxic T cells in extranodal, and predominantly in B cells in nodal T non-Hodgkin lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206556

An Epstein-Barr-related herpesvirus from marmoset lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206556

Persistence of Epstein-Barr virus in Reed-Sternberg cells throughout the course of Hodgkin's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206556

Epstein-Barr virus latent membrane protein 1 (LMP1) activates the phosphatidylinositol 3-kinase/Akt pathway to promote cell survival and induce actin filament remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206556

Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206556

The oncogenic protein kinase Tpl-2/Cot contributes to Epstein-Barr virus-encoded latent infection membrane protein 1-induced NF-kappaB signaling downstream of TRAF2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206556

Activation of the p38 mitogen-activated protein kinase pathway by Epstein-Barr virus-encoded latent membrane protein 1 coregulates interleukin-6 and interleukin-8 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206556

South Asian ethnicity and material deprivation increase the risk of Epstein-Barr virus infection in childhood Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206556

The immunoreceptor tyrosine-based activation motif of Epstein-Barr virus LMP2A is essential for blocking BCR-mediated signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206556

Assessment of the prognostic impact of the Epstein-Barr virus-encoded latent membrane protein-1 expression in Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206556

Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206556

The Epstein-Barr virus nuclear antigen 2 transactivator is directed to response elements by the J kappa recombination signal binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206556

Relation of Burkitt's tumor-associated herpes-ytpe virus to infectious mononucleosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206556

Co-localization of the retinoblastoma protein and the Epstein-Barr virus-encoded nuclear antigen EBNA-5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206556

Clonal deleterious mutations in the IkappaBalpha gene in the malignant cells in Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206556

Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206556

Two small RNAs encoded by Epstein-Barr virus and complexed with protein are precipitated by antibodies from patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206556

Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206556

Hodgkin's disease and Epstein-Barr virus. Altered antibody pattern before diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206556

Immunohistochemical demonstration of the Epstein-Barr virus-encoded latent membrane protein in paraffin sections of Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206556

Epstein-Barr virus-negative post-transplant lymphoproliferative disorders: a distinct entity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206556

Hodgkin's disease and peripheral T-cell lymphoma: composite lymphoma with evidence of Epstein-Barr virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206556

c-myc activation renders proliferation of Epstein-Barr virus (EBV)-transformed cells independent of EBV nuclear antigen 2 and latent membrane protein 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206556

Epstein-Barr Virus DNA recombination and loss in sporadic Burkitt's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206556

Epstein-Barr virus and carcinomas: rare association of the virus with gastric adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206556

Epstein-Barr virus small RNAs potentiate tumorigenicity of Burkitt lymphoma cells independently of an effect on apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206556

Epstein-Barr virus LMP2A transforms epithelial cells, inhibits cell differentiation, and activates Akt.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206556

Epstein-Barr virus-associated gastric adenocarcinomas among Koreans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206556

Transcriptional analysis of Epstein-Barr virus gene expression in EBV-positive gastric carcinoma: unique viral latency in the tumour cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206556

Viral interleukin 10 (IL-10), the human herpes virus 4 cellular IL-10 homologue, induces local anergy to allogeneic and syngeneic tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206556

Epstein-Barr virus-transforming protein latent infection membrane protein 1 activates transcription factor NF-kappaB through a pathway that includes the NF-kappaB-inducing kinase and the IkappaB kinases IKKalpha and IKKbeta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206556

EBNA-5, an Epstein-Barr virus-encoded nuclear antigen, binds to the retinoblastoma and p53 proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206556

The Epstein-Barr virus (EBV) small RNA EBER1 binds and relocalizes ribosomal protein L22 in EBV-infected human B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206556

Uterine cervical lymphoepithelial-like carcinoma. Absence of Epstein-Barr virus genomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206556

Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206556

Epstein-Barr virus gene expression in nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206556

Epstein-Barr virus nuclear antigen EBNA3C/6 expression maintains the level of latent membrane protein 1 in G1-arrested cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206556

7 January 2021

Epstein-Barr virus and Hodgkin's disease: further evidence for the three disease hypothesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206556

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206556

1 reference

7 January 2021

DNA sequence and expression of the B95-8 Epstein-Barr virus genome.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206556

7 January 2021

Transcripts from the Epstein-Barr virus BamHI A fragment are detectable in all three forms of virus latency.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206556

7 January 2021

Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206556

7 January 2021

Epstein-Barr virus and survival after Hodgkin disease in a population-based series of women

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206556

7 January 2021

Regulation of the interferon-inducible eIF-2 alpha protein kinase by small RNAs.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206556

7 January 2021

Lymphoepithelioma-like carcinoma of the breast: lack of evidence of Epstein-Barr virus infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206556

7 January 2021

Epstein-Barr virus-negative lymphoproliferate disorders in long-term survivors after heart, kidney, and liver transplant

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206556

7 January 2021

Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-kappaB pathway involving TNF receptor-associated factors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206556

7 January 2021

Activation of the cJun N-terminal kinase (JNK) pathway by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206556

7 January 2021

VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206556

7 January 2021

Oral excretion of Epstein-Barr virus by healthy subjects and patients with infectious mononucleosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206556

7 January 2021

Epstein-Barr virus latent membrane protein-1 (LMP-1) expression in oral squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206556

7 January 2021

Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206556

7 January 2021

Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206556

7 January 2021

Herpes-Type Virus and Chromosome Marker in Normal Leukocytes after Growth with Irradiated Burkitt Cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206556

7 January 2021

The Epstein-Barr virus latent membrane protein 2A PY motif recruits WW domain-containing ubiquitin-protein ligases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206556

7 January 2021

Essential role for T cells in human B-cell lymphoproliferative disease development in severe combined immunodeficient mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206556

7 January 2021

In vitro production of stable Epstein-Barr virus-positive epithelial cell clones which resemble the virus:cell interaction observed in nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206556

7 January 2021

Elevated antibody titers to Epstein-Barr virus in Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206556

7 January 2021

Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206556

7 January 2021

Pathogenesis of Burkitt lymphoma: expression of an activated c-myc oncogene causes the tumorigenic conversion of EBV-infected human B lymphoblasts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206556

7 January 2021

A second Epstein-Barr virus membrane protein (LMP2) is expressed in latent infection and colocalizes with LMP1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206556

7 January 2021

Integral membrane protein 2 of Epstein-Barr virus regulates reactivation from latency through dominant negative effects on protein-tyrosine kinases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206556

7 January 2021

An animal model for acute and persistent Epstein-Barr virus infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206556

7 January 2021

Expression of the tumour necrosis factor receptor-associated factors 1 and 2 in Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206556

7 January 2021

Transcription start sites downstream of the Epstein-Barr virus (EBV) Fp promoter in early-passage Burkitt lymphoma cells define a fourth promoter for expression of the EBV EBNA-1 protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206556

7 January 2021

Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206556

7 January 2021

The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206556

7 January 2021

Non-immortalizing P3J-HR-1 Epstein-Barr virus: a deletion mutant of its transforming parent, Jijoye

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206556

7 January 2021

Epstein-Barr virus EBNA3C represses Cp, the major promoter for EBNA expression, but has no effect on the promoter of the cell gene CD21.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206556

7 January 2021

Epstein-Barr virus nuclear antigen 3C interacts with histone deacetylase to repress transcription

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206556

7 January 2021

Activation of a ras-MAPK-dependent pathway by Epstein-Barr virus latent membrane protein 1 is essential for cellular transformation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206556

7 January 2021

Modulation of vimentin, the CD40 activation antigen and Burkitt's lymphoma antigen (CD77) by the Epstein-Barr virus nuclear antigen EBNA-4.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206556

7 January 2021

Oropharyngeal excretion of Epstein-Barr virus by renal transplant recipients and other patients treated with immunosuppressive drugs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206556

7 January 2021

Detection of Epstein-Barr virus (EBV) in hepatocellular carcinoma tissue: a novel EBV latency characterized by the absence of EBV-encoded small RNA expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206556

7 January 2021

Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206556

7 January 2021

An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206556

7 January 2021

In situ detection of Epstein-Barr virus in gastric and colorectal adenocarcinomas.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206556

7 January 2021

Epstein–Barr Virus in Burkitt's Lymphoma and Nasopharyngeal Carcinoma: EBV DNA in Biopsies of Burkitt Tumours and Anaplastic Carcinomas of the Nasopharynx

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206556

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1206556

1 reference

Dimensions Publication ID

31 July 2017

1025864988

0 references

1 reference